ModifiedCapital BluecrossPolicy MP 2.045

Diagnosis of Obstructive Sleep Apnea

This policy governs indications and testing approaches for diagnosing obstructive sleep apnea (OSA), including when home unattended sleep studies or in-lab polysomnography are considered medically necessary, and applies to Capital BlueCross products as specified.

Policy Summary

PayerCapital Bluecross

PolicyDiagnosis of Obstructive Sleep Apnea

Policy CodePolicy MP 2.045

Change TypeMajor content revision with coding movement and editorial updates

Effective DateDec 1, 2025

Next Review Date

Key ActionVerify member benefits and prior authorization requirements and use the updated coding guidance (note: medical management codes moved to MP 6.064).

SourceLink

POLICY UPDATE CHANGES

Condensed and reformatted criteria for sleep studies; added statement for home sleep testing (HST) prior to bariatric surgery; moved medical management and associated codes to newly created policy MP 6.064.

Removed investigational statement for multiple consecutive nights of sleep study and for video EEG monitoring.

Clarified that retesting after surgery is medically necessary for both adults and pediatrics.

Removed Benefit Variations Section and updated Disclaimer.

Editorial updates to statement; no change to intent. Background, definitions, coding table, and references updated.

3minimum channels (home)

AHI ≥15adult PAP threshold

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

adult symptomatic threshold

AHI ≥1.5pediatric abnormal threshold

MP 6.064medical mgmt moved

Coverage Criteria for Sleep Studies and OSA Diagnosis

Initial Unattended Home Sleep Study (Adults)

Covered when ALL of the following are met:

Home test adult criteria: Adult patient at high pretest probability for obstructive sleep apnea (e.g., habitual snoring, observed apneas, excessive daytime sleepiness, or BMI > 35 kg/m2)high pretest probability defined by symptoms such as habitual snoring, observed apneas, excessive daytime sleepiness, or BMI>35 kg/m2

Policy Guidelines define high pretest probability

No contraindicating conditions: No evidence of conditions that might alter ventilation or require alternative treatment (e.g., central sleep apnea, heart failure, chronic pulmonary disease, obesity hypoventilation syndrome, neuromuscular disorders with sleep-related symptoms, injurious parasomnias, or narcolepsy)

Presence of these conditions requires in-lab testing

Device/channel requirements: Single unattended home sleep study using at least 3 recording channels (nasal pressure, chest and abdominal respiratory inductance plethysmography, and oximetry) or alternatively peripheral arterial tone (PAT), oximetry, and actigraphy>=3 channels

Type 3/4 device guidance; minimum channels described in policy

Bariatric Surgery Patients - Home Test Screening

Covered as a screening tool when ALL of the following are met:

Bariatric patient screening: Individual scheduled for bariatric surgery

Screening recommended routinely due to high prevalence of OSA in this population

No contraindicating conditions: No evidence of conditions that might alter ventilation or require alternative treatment (obesity hypoventilation syndrome should be ruled out prior to home testing)

Obesity hypoventilation syndrome must be ruled out before HST in bariatric candidates

Initial Testing Performed in a Sleep Laboratory

Covered when ANY of the following are met:

Indications for in-lab PSG: Pediatric individuals (<18 years); OR patient does not meet criteria for an unattended home sleep study; OR previous home study failed to establish diagnosis or was technically inadequate; OR failure or recurrence of symptoms during treatment; OR testing to rule out other sleep disorders (e.g., central sleep apnea, injurious parasomnias, narcolepsy); OR presence of comorbidity that might alter ventilation (e.g., heart failure, neuromuscular disease, chronic pulmonary disease, obesity hypoventilation syndrome)

Interpretation should be performed and raw data reviewed by a physician trained in sleep medicine

Repeat Unattended Home Sleep Study

Covered when ANY of the following are met:

Repeat home testing indications: To assess efficacy of surgery or oral appliances/devices; OR to re-evaluate the diagnosis of OSA and need for continued CPAP therapy after a significant change in weight or change in symptoms suggesting adjustment or discontinuation of therapy

Repeat unattended home sleep studies require minimum 3 recording channels and are limited to adult patients under these circumstances

Repeat/In-Lab PSG for PAP Initiation and Titration

Covered when ALL of the following are met:

Adult PAP initiation/titration: Adult patient with AHI or RDI ≥15 events per hour OR AHI/RDI ≥5 events per hour in an individual with one or more signs or symptoms associated with OSA (e.g., excessive daytime sleepiness, hypertension, cardiovascular disease, stroke)AHI/RDI ≥15 or ≥5 with symptoms

Indication for repeat in-lab PSG to initiate and titrate PAP therapy

Pediatric PAP initiation/titration: Pediatric individual meeting criteria for in-lab testing with AHI/RDI ≥5 OR AHI/RDI ≥1.5 in an individual with excessive daytime sleepiness, behavioral problems, or hyperactivityAHI/RDI ≥5 (or ≥1.5 symptomatic)

Pediatric thresholds differ from adults for PAP initiation/titration

Split-Night Study

A split-night study is acceptable when ALL of the following are met:

Split-night criteria 1: An AHI of at least 40 events per hour documented during a minimum of 2 hours of diagnostic PSG (split-night studies may sometimes be considered at an AHI between 20 and 40 based on clinical judgment)AHI ≥40 (or 20–40 by judgment)

Higher AHI favors split-night; lower AHI may reduce accuracy

Split-night criteria 2: CPAP titration is carried out for more than 3 hours during the same night>3 hours CPAP titration

Respiratory events can worsen as night progresses

Split-night criteria 3: PSG documents that CPAP eliminates or nearly eliminates respiratory events during REM and non-REM sleep, including REM supine position

If not met, a second full night of PSG for titration is indicated

Diagnostic Coverage Criteria

Covered diagnostic approaches and limits

In-lab polysomnography: Polysomnography performed in a sleep laboratory is the criterion standard for diagnosis and includes EEG, EMG, EOG, ECG, airflow, respiratory effort, snoring, oxygen desaturation, and sleep position; attended studies allow split-night CPAP titration

Attended PSG permits monitoring to ensure adequate sensor function and immediate titration

Home sleep apnea testing (HSAT) with ≥3 channels: For adults with a high pretest probability of OSA and absence of comorbid conditions, home sleep apnea testing with at least three recording channels (e.g., airflow, respiratory effort, oximetry) or alternatively PAT, actigraphy and oximetry is noninferior to in-lab testing and may be used to diagnose OSA and justify a CPAP trial>=3 recording channels

RCT evidence supports noninferiority in selected adults; positive HSAT can be used as basis for CPAP trial

Limitations of limited-channel HSAT: Limited-channel home sleep apnea testing that lacks sensors for respiratory effort, airflow, and oxygen saturation is insufficiently supported and is considered investigational/not adequate to detect clinically significant OSA

Summary of coverage changes

Policy-level coverage direction and changes

Recent major review changes: 02/03/2025 major review: condensed and reformatted criteria for sleep studies; added statement for home sleep testing (HST) prior to bariatric surgery; moved medical management and associated codes to newly created policy MP 6.064

Material policy-level change noted in policy history

Removed statements: Investigational statement for multiple consecutive nights of sleep study and investigational statement for video EEG monitoring were removed during the 02/03/2025 review

Clarification: re-testing after surgery was clarified as medically necessary for adults and pediatrics

Administrative updates: 06/23/2025 administrative update removed Benefit Variations section and updated Disclaimer; 08/08/2025 editorial consensus review updated background, definitions, coding table, and references without changing intent

Non-material editorial updates noted

Unattended (home) sleep studies are investigational in children (less than 18 years of age) and are not supported by sufficient evidence for routine use in the pediatric population. Multiple sleep latency testing is also considered investigational in the diagnosis of OSA and is not an accepted diagnostic substitute for polysomnography or appropriate home testing when evaluating suspected obstructive sleep apnea.

Limited-channel home sleep apnea testing that does not include sensors for respiratory effort, airflow, and oxygen saturation (or alternatively peripheral arterial tone, actigraphy, and oximetry) is considered investigational and not covered. Procedure codes specifically identified as investigational/not covered in this policy include 94799 and 95805. Providers should ensure home testing devices meet minimum channel/sensor requirements and applicable CPT coding conventions (for example, CPT codes that distinguish attended vs unattended polygraphic studies) when submitting claims.

The policy history documents that the prior investigational statements for performing multiple consecutive nights of sleep study and for video EEG monitoring were removed during the 02/03/2025 major review. These items are no longer listed as investigational in the current policy version.

Supervised or unattended sleep studies that fail to meet the policy's required device/channel configuration, patient selection criteria, or clinical indications are considered investigational / not medically necessary. The policy emphasizes that portable monitoring should permit raw-data review by clinicians trained in sleep medicine and that devices with fewer than recommended channels (or performed in patients with contraindicating comorbidities) do not meet coverage criteria.

Testing modalities that lack adequate physiologic channels—specifically absence of measures of respiratory effort, airflow, and oximetry (or the acceptable alternative sensor set)—are unsupported by the evidence and are considered investigational / not medically necessary. The literature does not demonstrate sufficient diagnostic accuracy or health outcome benefit for limited-channel approaches that omit these essential sensors.

The prior policy statement categorizing re-evaluation via in-lab polysomnography after weight change as not medically necessary was removed in the 02/03/2025 major review. The current policy text clarifies re-testing after surgery or significant weight change may be medically necessary under specified circumstances.

Procedure and Diagnosis Codes

Example polygraphic CPT codes discussedCPT

95806	Unattended (home) polygraphic sleep study
95807	Attended polygraphic sleep study

Investigational / Not Covered Procedure CodesCPTNot Covered

94799	Investigational; therefore, not covered (per policy)
95805	Investigational; therefore, not covered (per policy)

Covered Procedure CodesmixedCovered

G0400	Covered when medically necessary (listed in policy)
95801	Covered when medically necessary
95806	Covered when medically necessary
95807	Covered when medically necessary
95808	Covered when medically necessary
95810	Covered when medically necessary
95811	Covered when medically necessary
G0398	Covered when medically necessary
G0399	Covered when medically necessary

Relevant Diagnosis CodesICD-10

G47.30	Sleep apnea, unspecified
G47.33	Obstructive sleep apnea (adult) (pediatric) - for repeat testing only
G47.8	Other sleep disorders
G47.9	Sleep disorder unspecified
R06.81	Apnea, not elsewhere classified
R40.0	Somnolence

Policy-related codes (historical and updates)mixed

K1001	previously listed; deleted 01/01/2024
K1027	added 10/01/2021
K1028	added 04/01/2022; later deleted
K1029	added 04/01/2022; later deleted
A7049	added effective 04/01/2023
E0490	added as investigational effective 10/01/2023
E0491	added as investigational effective 10/01/2023
E0492	added (12/13/2023)
E0493	added (12/13/2023)
E0530	added (12/13/2023)

AHI/RDI thresholds — Adults and Pediatrics thresholds summary

Adults - PAP initiation/titrationAHI or RDI ≥15 events/hour; or AHI/RDI ≥5 with one or more OSA signs or symptoms (e.g., excessive daytime sleepiness, hypertension, cardiovascular disease, stroke)

Pediatrics - PAP initiation/titrationAHI/RDI ≥5; or AHI/RDI ≥1.5 with excessive daytime sleepiness, behavioral problems, or hyperactivity

Pediatric abnormal threshold (diagnostic)An AHI or RDI ≥1.5 events/hour is considered abnormal in children

AHI thresholds — severity classification adults and children

Adults - MildAHI or RDI 5 to <15 events/hour

Provider Responsibilities, Prior Authorization, and Billing Guidance

Prior Authorization

Coding and Prior Authorization Note

Ensure correct coding and prior authorization: distinguish attended vs unattended polygraphic studies when selecting CPT codes and verify prior authorization requirements for the specific product. Use PSG (with EEG) codes for studies including EEG and the appropriate polygraphic (non‑EEG) codes for studies without EEG. There is no CPT code that explicitly denotes 'unattended' PSG; attach GT modifier for remotely monitored studies when appropriate. Incorrect code choice or use of moved codes may result in claim denials.

CPT codes distinguish studies that include EEG (PSG) from polygraphic studies without EEG.
CPT 95807 and 95806 distinguish attended vs unattended polygraphic sleep studies; no CPT code specifically denotes 'unattended' PSG.
Remotely monitored home studies may be reported with the study CPT plus GT modifier when interactive audio/video is used.
Prior authorization applicability varies by product — confirm member benefit and any PA requirements before testing.

Note

Product / Benefit Variations and Coding

Background and Scope

Obstructive sleep apnea (OSA) is a sleep-related breathing disorder characterized by recurrent upper-airway obstruction during sleep, typically presenting with habitual snoring, witnessed apneas, and daytime sleepiness. Risk factors include obesity (e.g., BMI >35 kg/m2), loud habitual snoring, and observed apneas; OSA is substantially underdiagnosed in the population. Diagnosis relies on physiologic monitoring—in-lab polysomnography (PSG) is the criterion standard and records EEG plus respiratory and cardiovascular parameters, while appropriately selected home sleep testing with adequate channels (minimum of 3 recording channels in the adult population) may be used for adults at high pretest probability and without comorbid conditions that might alter ventilation.

Definitions and Severity Metrics

PSG/monitoring types (Type 1–4) definitions

Type 1Standard attended in‑lab comprehensive polysomnography (PSG) — full EEG and multiple physiologic channels

Type 2Comprehensive portable PSG — full polysomnographic recording in an unattended setting

Type 3Modified portable sleep apnea testing (cardiorespiratory) — 4 or more channels (e.g., airflow, respiratory effort, oximetry)

Type 4Continuous single or dual bioparameters — 1–2 channels (typically oximetry or airflow)

Split-night study definition

DefinitionSplit‑night study: initial diagnostic PSG followed by same‑night CPAP/PAP titration when moderate‑to‑severe OSA is documented and criteria are met (see minimum documented AHI and titration duration)

Policy Revision History

2025-02-03major_review

Major review: moved medical management and associated codes to new policy MP 6.064; condensed and reformatted sleep study criteria; added statement for home sleep testing prior to bariatric surgery; removed investigational statements for multiple consecutive nights of sleep study and for video EEG monitoring; clarified that re-testing after surgery is medically necessary for adults and pediatrics.

2025-06-23administrative_update

Administrative update: removed Benefit Variations section and updated Disclaimer.

2025-08-08consensus_review

Policy Summary

PayerCapital Bluecross

PolicyDiagnosis of Obstructive Sleep Apnea

Policy CodePolicy MP 2.045

Change TypeMajor content revision with coding movement and editorial updates

Effective DateDec 1, 2025

Next Review Date

Key ActionVerify member benefits and prior authorization requirements and use the updated coding guidance (note: medical management codes moved to MP 6.064).

SourceLink

On This Page

Insufficient evidence; investigational (see policy coding and exclusions)

Negative or nonresponsive HSAT pathway: A negative portable monitoring study cannot reliably rule out OSA; patients with negative HSAT or those with positive HSAT who do not respond to CPAP should undergo further evaluation, typically in-lab PSG

Described in policy rationale and evidence summary

Adults - ModerateAHI or RDI 15 to <30 events/hour

Adults - SevereAHI or RDI ≥30 events/hour

Children - AbnormalAHI or RDI ≥1.5 events/hour considered abnormal

Children - SevereAHI ≥10 events/hour may be considered severe

Policy coding movement — medical management codes moved to MP 6.064

Policy movementMedical management and associated codes were moved to newly created policy MP 6.064

Implication for prior authorizationPrior authorization requirements for medical management services may now be handled under MP 6.064

Denial riskChanges in coding location may trigger denials if claims use codes no longer supported in this policy

Product and benefit variations affect coverage and coding. This policy applies only to certain Capital Blue Cross administered programs; member-specific benefits determine coverage and reimbursement. Refer to program-specific guidance (e.g., FEP PPO references) and the member’s plan prior to ordering or billing any sleep study.

Check member benefits for coverage differences, prior authorization, and medical necessity requirements.
FEP PPO: refer to the FEP Medical Policy Manual for plan-specific policy language and requirements.

Documentation Required

Home (Unattended) Sleep Studies

Home (unattended) sleep studies: use only when policy criteria are met. A single unattended home sleep apnea test with the required minimum recording channels may be considered medically necessary in adults with high pretest probability of OSA and no conditions that might alter ventilation. Unattended home studies are investigational in children (<18 years).

Minimum channel requirements must be met (see Documentation and Minimum Channels callout).
Unattended HST is intended for adults without comorbidities that alter ventilation (e.g., central sleep apnea, heart failure, chronic pulmonary disease, obesity hypoventilation syndrome, neuromuscular disorders).
If criteria are not met, an attended in‑lab PSG is the appropriate test.

Denial Risk

Limited-Channel Home Sleep Apnea Testing

Limited‑channel home sleep apnea testing (devices with fewer than required sensors) is considered investigational and not supported. Devices lacking sensors for respiratory effort, airflow, and oxygen saturation (or the alternative PAT/actigraphy/oximetry combination) have insufficient evidence to detect clinically significant OSA reliably.

Type 4 monitors with fewer than 3 channels are not recommended due to reduced diagnostic accuracy and higher failure rates.
Limited‑channel testing should not be used as a basis for diagnosis or CPAP initiation.

Billing Rule

Coding / Coding Location Changes

Coding and code-location changes: apply current codes and note recent policy moves. Medical management codes were moved to MP 6.064; continued use of old locations or retired codes may cause claim denials. Review the coding section for investigational or deleted codes and update billing accordingly.

Medical management and associated codes moved to MP 6.064 (effective 02/03/2025).
Investigational / not covered codes include 94799 and 95805; monitor coding table updates regularly.
Claims using deleted or deprecated codes or referencing moved-code locations may be denied—verify current code table before billing.

Documentation Required

Documentation Should Support Pretest Probability and Comorbid Conditions

Documentation must support pretest probability and presence/absence of comorbid conditions. Clinical documentation should demonstrate high or moderate pretest probability for OSA, signs/symptoms (e.g., daytime sleepiness, hypertension, cardiovascular disease), and absence of conditions that would alter ventilation when ordering unattended HST. For bariatric surgery candidates, document the indication if using HST as a screening tool.

Document signs/symptoms and pretest probability assessment in the medical record.
Document any comorbidities that would necessitate in‑lab PSG instead of HST.
For bariatric surgery screening, include documentation that patient has no conditions that might alter ventilation.

Note

Use Updated Coding and Definitions

Use updated coding and definitions per policy editorial updates. Providers must follow the revised code tables and definitions in this policy; editorial updates may change code lists, descriptions, or status (covered vs investigational). Staying current avoids billing errors and denials.

Review the policy's coding information (Section VII) for the most current code list and statuses.
Editorial updates (e.g., 08/08/2025) may alter coding or definitions—apply the latest effective guidance.

Documentation Required

Split-Night Study Usage

A split‑night study may be used to both diagnose moderate‑to‑severe OSA and titrate CPAP in the same night when the diagnostic portion documents sufficient severity. If successful, split‑night testing can eliminate the need for a second PSG for titration—ensure documentation of diagnostic AHI/RDI and titration outcomes in the report.

Split‑night studies are appropriate when moderate‑to‑severe OSA is documented during the diagnostic portion of the night.
Document the AHI/RDI used to determine need for same‑night titration and CPAP settings achieved.

Note

Positive Portable Monitoring as Basis for CPAP Trial

A positive portable monitoring (home) study with adequate channels (arterial oxygen saturation, airflow, and respiratory effort; or PAT + actigraphy + oximetry) has a high positive predictive value for OSA and may be used as the basis for initiating a CPAP trial to assess treatment efficacy. Negative portable studies do not rule out OSA and should prompt further evaluation when clinical suspicion remains high.

Positive portable monitoring with required sensors can justify initiation of CPAP.
If portable monitoring is negative but clinical suspicion persists, refer for in‑lab PSG.

Documentation Required

Interpretation and Raw Data Review Requirements

Provider qualification and data review: professionals interpreting PSG or HST must be trained in sleep medicine and should review raw data to detect artifacts and data loss. This applies to both attended polysomnography and home sleep studies to ensure test quality and accurate interpretation.

Interpretation and raw data review should be performed by a physician or qualified professional trained in sleep medicine.
Review raw data from home devices to identify artifacts, data loss, or technical failures before final interpretation.

Minimum AHI for considerationAHI of at least 40 events/hour documented during a minimum of 2 hours of diagnostic PSG (sometimes considered between 20–40 based on clinical judgment)

Titration requirementCPAP titration carried out for more than 3 hours and PSG demonstrates elimination or near elimination of events during REM and non‑REM sleep

Apnea definition (adult and pediatric)

Adult apnea definitionDrop in airflow by ≥90% of pre‑event baseline for at least 10 seconds

Pediatric apnea definitionDefined as 2 or more missed breaths (regardless of duration in seconds)

Measurement channelsFrequency measured from channels assessing airflow, respiratory effort, and oxygen desaturation

Hypopnea definition (adult and pediatric)

Adult hypopnea definition≥30% drop in peak airflow for ≥10 seconds with either ≥4% arterial oxygen desaturation or an arousal

Pediatric hypopnea definition≥50% drop in nasal pressure with either ≥3% oxygen desaturation or an associated arousal

RERA noteRespiratory event‑related arousal (RERA) lasts ≥10 seconds with nasal pressure flattening or increased effort, terminating in arousal but not meeting apnea/hypopnea criteria

AHI / RDI / REI definitions and distinctions (home vs in-lab)

AHIApnea‑Hypopnea Index: average number of apneas plus hypopneas per hour of sleep (requires EEG to determine sleep time)

RDIRespiratory Disturbance Index: number of apneas, hypopneas, or RERAs per hour of sleep (often used synonymously with AHI)

REIRespiratory Event Index: number of events per hour of monitoring time — used in home studies when actual sleep time by EEG is not available

OSA severity (Adults) — mild/moderate/severe thresholds

Mild OSA (Adults)AHI or RDI 5 to <15 events/hour

Moderate OSA (Adults)AHI or RDI 15 to <30 events/hour

Severe OSA (Adults)AHI or RDI ≥30 events/hour

OSA severity (Children) — abnormal and severe thresholds

Abnormal OSA (Children)An AHI or RDI ≥1.5 events/hour is considered abnormal in children

Severe OSA (Children)An AHI ≥10 events/hour may be considered severe

Clinical presentation noteChildren often present with behavioral problems or hyperactivity rather than daytime sleepiness

HST abbreviation/term

HSTHome Sleep Testing — portable/unattended sleep testing performed outside the sleep laboratory (also called HSAT or HST)

UsageUsed for adults with high pretest probability of OSA and absence of comorbid conditions when devices include required channels

REI relevanceHome studies commonly report REI (events per hour of monitoring time) when EEG sleep time is not recorded

PSG abbreviation/term

PSGPolysomnography (PSG): comprehensive sleep study including EEG, EOG, EMG and multiple physiologic channels, usually performed attended in a sleep laboratory (Type 1)

ScopePSG may also be performed with Type 2 portable monitoring but typically denotes studies with EEG to determine sleep time

Distinction from polygraphic studiesPSG includes EEG; polygraphic (non‑EEG) sleep studies correspond to Types 3–4

Consensus review (editorial): editorial updates to statements with no change in intent; background, definitions, coding table, and references updated.